Selected research
Market Structure
Global Tranexamic Acid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Tranexamic Acid market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Tranexamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Tranexamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tranexamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Tranexamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Tranexamic Acid include Venkata Sai Life Sciences, Aquatic Remedies, Taicang Pharmaceutical Factory, Shilpa Medicare Limited, Yangtze River Pharmaceutical Group, Dongting Pharma and Huluwa Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Tranexamic Acid output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Tranexamic Acid by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Tranexamic Acid market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Tranexamic Acid and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Tranexamic Acid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tranexamic Acid market size, projected growth trends, production technologies, key applications, and end-use industries.
Tranexamic Acid Segment by Company
Venkata Sai Life Sciences
Aquatic Remedies
Taicang Pharmaceutical Factory
Shilpa Medicare Limited
Yangtze River Pharmaceutical Group
Dongting Pharma
Huluwa Pharma
Tranexamic Acid Segment by Type
USP25
BP2000
Others
Tranexamic Acid Segment by Application
Trauma
Craniocerebral Trauma
Menorrhagia
Postpartum Hemorrhage
Surgery
Whitening Cosmetics
Others
Tranexamic Acid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tranexamic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tranexamic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tranexamic Acid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Tranexamic Acid market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tranexamic Acid industry.
Chapter 3: Detailed analysis of Tranexamic Acid market competition landscape. Including Tranexamic Acid manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Tranexamic Acid by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Tranexamic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- USP25
- BP2000
- Others
Applications
- Trauma
- Craniocerebral Trauma
- Menorrhagia
- Postpartum Hemorrhage
- Surgery
- Whitening Cosmetics
- Others
Companies covered
- Venkata Sai Life Sciences
- Aquatic Remedies
- Taicang Pharmaceutical Factory
- Shilpa Medicare Limited
- Yangtze River Pharmaceutical Group
- Dongting Pharma
- Huluwa Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Tranexamic Acid Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Tranexamic Acid Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Tranexamic Acid Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Tranexamic Acid Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Tranexamic Acid Market Dynamics
- 2.1 Tranexamic Acid Industry Trends
- 2.2 Tranexamic Acid Industry Drivers
- 2.3 Tranexamic Acid Industry Opportunities and Challenges
- 2.4 Tranexamic Acid Industry Restraints
3 Tranexamic Acid Market by Manufacturers
- 3.1 Global Tranexamic Acid Production Value by Manufacturers (2021-2026)
- 3.2 Global Tranexamic Acid Production by Manufacturers (2021-2026)
- 3.3 Global Tranexamic Acid Average Price by Manufacturers (2021-2026)
- 3.4 Global Tranexamic Acid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Tranexamic Acid Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Tranexamic Acid Manufacturers, Product Type & Application
- 3.7 Global Tranexamic Acid Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Tranexamic Acid Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Tranexamic Acid Players Market Share by Production Value in 2025
- 3.8.3 2025 Tranexamic Acid Tier 1, Tier 2, and Tier 3
4 Tranexamic Acid Market by Type
- 4.1 Tranexamic Acid Type Introduction
- 4.1.1 USP25
- 4.1.2 BP2000
- 4.1.3 Others
- 4.2 Global Tranexamic Acid Production by Type
- 4.2.1 Global Tranexamic Acid Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Tranexamic Acid Production by Type (2021-2032)
- 4.2.3 Global Tranexamic Acid Production Market Share by Type (2021-2032)
- 4.3 Global Tranexamic Acid Production Value by Type
- 4.3.1 Global Tranexamic Acid Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Tranexamic Acid Production Value by Type (2021-2032)
- 4.3.3 Global Tranexamic Acid Production Value Market Share by Type (2021-2032)
5 Tranexamic Acid Market by Application
- 5.1 Tranexamic Acid Application Introduction
- 5.1.1 Trauma
- 5.1.2 Craniocerebral Trauma
- 5.1.3 Menorrhagia
- 5.1.4 Postpartum Hemorrhage
- 5.1.5 Surgery
- 5.1.6 Whitening Cosmetics
- 5.1.7 Others
- 5.2 Global Tranexamic Acid Production by Application
- 5.2.1 Global Tranexamic Acid Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Tranexamic Acid Production by Application (2021-2032)
- 5.2.3 Global Tranexamic Acid Production Market Share by Application (2021-2032)
- 5.3 Global Tranexamic Acid Production Value by Application
- 5.3.1 Global Tranexamic Acid Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Tranexamic Acid Production Value by Application (2021-2032)
- 5.3.3 Global Tranexamic Acid Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Venkata Sai Life Sciences
- 6.1.1 Venkata Sai Life Sciences Company Information
- 6.1.2 Venkata Sai Life Sciences Business Overview
- 6.1.3 Venkata Sai Life Sciences Tranexamic Acid Production, Value and Gross Margin (2021-2026)
- 6.1.4 Venkata Sai Life Sciences Tranexamic Acid Product Portfolio
- 6.1.5 Venkata Sai Life Sciences Recent Developments
- 6.2 Aquatic Remedies
- 6.2.1 Aquatic Remedies Company Information
- 6.2.2 Aquatic Remedies Business Overview
- 6.2.3 Aquatic Remedies Tranexamic Acid Production, Value and Gross Margin (2021-2026)
- 6.2.4 Aquatic Remedies Tranexamic Acid Product Portfolio
- 6.2.5 Aquatic Remedies Recent Developments
- 6.3 Taicang Pharmaceutical Factory
- 6.3.1 Taicang Pharmaceutical Factory Company Information
- 6.3.2 Taicang Pharmaceutical Factory Business Overview
- 6.3.3 Taicang Pharmaceutical Factory Tranexamic Acid Production, Value and Gross Margin (2021-2026)
- 6.3.4 Taicang Pharmaceutical Factory Tranexamic Acid Product Portfolio
- 6.3.5 Taicang Pharmaceutical Factory Recent Developments
- 6.4 Shilpa Medicare Limited
- 6.4.1 Shilpa Medicare Limited Company Information
- 6.4.2 Shilpa Medicare Limited Business Overview
- 6.4.3 Shilpa Medicare Limited Tranexamic Acid Production, Value and Gross Margin (2021-2026)
- 6.4.4 Shilpa Medicare Limited Tranexamic Acid Product Portfolio
- 6.4.5 Shilpa Medicare Limited Recent Developments
- 6.5 Yangtze River Pharmaceutical Group
- 6.5.1 Yangtze River Pharmaceutical Group Company Information
- 6.5.2 Yangtze River Pharmaceutical Group Business Overview
- 6.5.3 Yangtze River Pharmaceutical Group Tranexamic Acid Production, Value and Gross Margin (2021-2026)
- 6.5.4 Yangtze River Pharmaceutical Group Tranexamic Acid Product Portfolio
- 6.5.5 Yangtze River Pharmaceutical Group Recent Developments
- 6.6 Dongting Pharma
- 6.6.1 Dongting Pharma Company Information
- 6.6.2 Dongting Pharma Business Overview
- 6.6.3 Dongting Pharma Tranexamic Acid Production, Value and Gross Margin (2021-2026)
- 6.6.4 Dongting Pharma Tranexamic Acid Product Portfolio
- 6.6.5 Dongting Pharma Recent Developments
- 6.7 Huluwa Pharma
- 6.7.1 Huluwa Pharma Company Information
- 6.7.2 Huluwa Pharma Business Overview
- 6.7.3 Huluwa Pharma Tranexamic Acid Production, Value and Gross Margin (2021-2026)
- 6.7.4 Huluwa Pharma Tranexamic Acid Product Portfolio
- 6.7.5 Huluwa Pharma Recent Developments
7 Global Tranexamic Acid Production by Region
- 7.1 Global Tranexamic Acid Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Tranexamic Acid Production by Region (2021-2032)
- 7.2.1 Global Tranexamic Acid Production by Region (2021-2026)
- 7.2.2 Global Tranexamic Acid Production Forecast by Region (2027-2032)
- 7.3 Global Tranexamic Acid Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Tranexamic Acid Production Value by Region (2021-2032)
- 7.4.1 Global Tranexamic Acid Production Value by Region (2021-2026)
- 7.4.2 Global Tranexamic Acid Production Value by Region (2027-2032)
- 7.5 Global Tranexamic Acid Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Tranexamic Acid Production Value (2021-2032)
- 7.6.2 Europe Tranexamic Acid Production Value (2021-2032)
- 7.6.3 Asia-Pacific Tranexamic Acid Production Value (2021-2032)
- 7.6.4 South America Tranexamic Acid Production Value (2021-2032)
- 7.6.5 Middle East & Africa Tranexamic Acid Production Value (2021-2032)
8 Global Tranexamic Acid Consumption by Region
- 8.1 Global Tranexamic Acid Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Tranexamic Acid Consumption by Region (2021-2032)
- 8.2.1 Global Tranexamic Acid Consumption by Region (2021-2026)
- 8.2.2 Global Tranexamic Acid Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Tranexamic Acid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Tranexamic Acid Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Tranexamic Acid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Tranexamic Acid Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Tranexamic Acid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Tranexamic Acid Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Tranexamic Acid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Tranexamic Acid Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Tranexamic Acid Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Tranexamic Acid Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Tranexamic Acid Value Chain Analysis
- 9.1.1 Tranexamic Acid Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Tranexamic Acid Production Mode & Process
- 9.2 Tranexamic Acid Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Tranexamic Acid Distributors
- 9.2.3 Tranexamic Acid Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst